Cargando…

Pregnancy outcome following opioid exposure: A cohort study

INTRODUCTION: Opioids constitute a cornerstone of pain relief treatment. However, opioid safety during pregnancy has not been well established. Recent studies reported an association between in utero opioid exposure and spina bifida. METHODS: In order to further evaluate the association of opioids e...

Descripción completa

Detalles Bibliográficos
Autores principales: Fishman, Boris, Daniel, Sharon, Koren, Gideon, Lunenfeld, Eitan, Levy, Amalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602193/
https://www.ncbi.nlm.nih.gov/pubmed/31260464
http://dx.doi.org/10.1371/journal.pone.0219061
_version_ 1783431351125409792
author Fishman, Boris
Daniel, Sharon
Koren, Gideon
Lunenfeld, Eitan
Levy, Amalia
author_facet Fishman, Boris
Daniel, Sharon
Koren, Gideon
Lunenfeld, Eitan
Levy, Amalia
author_sort Fishman, Boris
collection PubMed
description INTRODUCTION: Opioids constitute a cornerstone of pain relief treatment. However, opioid safety during pregnancy has not been well established. Recent studies reported an association between in utero opioid exposure and spina bifida. METHODS: In order to further evaluate the association of opioids exposure during pregnancy with adverse pregnancy outcomes, we conducted a large historical cohort by linking four databases: medications dispensations, births, pregnancy terminations for medical reasons and infant hospitalizations during the years of 1999–2009. Confounders that were controlled for included maternal age, ethnicity, maternal diabetes, smoking status, parity, obesity, year and folic acid intake. A secondary analysis for total major malformations and for spina bifida was performed using propensity score matching for first trimester exposure. RESULTS: Of the 101,586 women included in the study, 3003 were dispensed opioids during the first trimester. Intrauterine exposure to opioids was not associated with overall major malformations (adjusted odds ratio (aOR) 0.97, 95% CI 0.83–1.13), cardiovascular malformations (aOR = 0.89, 95% CI 0.70–1.13) other malformations by systems or spina bifida in particular. However, the risk for spina bifida among newborns and abortuses who were exposed to codeine was four times higher than that of the unexposed (aOR = 4.42, 95% CI 1.60–12.23). This association remained significant in a secondary analysis using propensity score matching. Third trimester exposure to opioids was not associated with low birth weight (aOR = 1.08, 95% CI 0.77–1.52), perinatal death (aOR = 1.38, 95% CI 0.64–2.99) and other adverse pregnancy outcomes. CONCLUSIONS: These findings suggest that opioids exposure (as a homogenous group) is not a significant risk factor for overall major malformations. Exposure to codeine during the first trimester was found to be associated with increased risk of spina bifida. However, this finding was based on a small number of cases and need to be verified in future work.
format Online
Article
Text
id pubmed-6602193
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-66021932019-07-12 Pregnancy outcome following opioid exposure: A cohort study Fishman, Boris Daniel, Sharon Koren, Gideon Lunenfeld, Eitan Levy, Amalia PLoS One Research Article INTRODUCTION: Opioids constitute a cornerstone of pain relief treatment. However, opioid safety during pregnancy has not been well established. Recent studies reported an association between in utero opioid exposure and spina bifida. METHODS: In order to further evaluate the association of opioids exposure during pregnancy with adverse pregnancy outcomes, we conducted a large historical cohort by linking four databases: medications dispensations, births, pregnancy terminations for medical reasons and infant hospitalizations during the years of 1999–2009. Confounders that were controlled for included maternal age, ethnicity, maternal diabetes, smoking status, parity, obesity, year and folic acid intake. A secondary analysis for total major malformations and for spina bifida was performed using propensity score matching for first trimester exposure. RESULTS: Of the 101,586 women included in the study, 3003 were dispensed opioids during the first trimester. Intrauterine exposure to opioids was not associated with overall major malformations (adjusted odds ratio (aOR) 0.97, 95% CI 0.83–1.13), cardiovascular malformations (aOR = 0.89, 95% CI 0.70–1.13) other malformations by systems or spina bifida in particular. However, the risk for spina bifida among newborns and abortuses who were exposed to codeine was four times higher than that of the unexposed (aOR = 4.42, 95% CI 1.60–12.23). This association remained significant in a secondary analysis using propensity score matching. Third trimester exposure to opioids was not associated with low birth weight (aOR = 1.08, 95% CI 0.77–1.52), perinatal death (aOR = 1.38, 95% CI 0.64–2.99) and other adverse pregnancy outcomes. CONCLUSIONS: These findings suggest that opioids exposure (as a homogenous group) is not a significant risk factor for overall major malformations. Exposure to codeine during the first trimester was found to be associated with increased risk of spina bifida. However, this finding was based on a small number of cases and need to be verified in future work. Public Library of Science 2019-07-01 /pmc/articles/PMC6602193/ /pubmed/31260464 http://dx.doi.org/10.1371/journal.pone.0219061 Text en © 2019 Fishman et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fishman, Boris
Daniel, Sharon
Koren, Gideon
Lunenfeld, Eitan
Levy, Amalia
Pregnancy outcome following opioid exposure: A cohort study
title Pregnancy outcome following opioid exposure: A cohort study
title_full Pregnancy outcome following opioid exposure: A cohort study
title_fullStr Pregnancy outcome following opioid exposure: A cohort study
title_full_unstemmed Pregnancy outcome following opioid exposure: A cohort study
title_short Pregnancy outcome following opioid exposure: A cohort study
title_sort pregnancy outcome following opioid exposure: a cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602193/
https://www.ncbi.nlm.nih.gov/pubmed/31260464
http://dx.doi.org/10.1371/journal.pone.0219061
work_keys_str_mv AT fishmanboris pregnancyoutcomefollowingopioidexposureacohortstudy
AT danielsharon pregnancyoutcomefollowingopioidexposureacohortstudy
AT korengideon pregnancyoutcomefollowingopioidexposureacohortstudy
AT lunenfeldeitan pregnancyoutcomefollowingopioidexposureacohortstudy
AT levyamalia pregnancyoutcomefollowingopioidexposureacohortstudy